Revolution Medicines (RVMD) Net Equity Issued and Repurchased (2019 - 2026)

Revolution Medicines (RVMD) posted quarterly Net Equity Issued and Repurchased of $141.9 million for Q1 2026, up 138.49% quarter-over-quarter from $59.5 million in Q4 2024.

Revolution Medicines (RVMD) Net Equity Issued and Repurchased (2019 - 2026) Analysis & Trends

Revolution Medicines' Net Equity Issued and Repurchased history runs 7 years deep, the most recent figure standing at $141.9 million for Q1 2026.

  • In Q1 2026, Net Equity Issued and Repurchased changed N/A year-over-year to $141.9 million; the TTM figure through Mar 2026 stood at $201.4 million (changed N/A YoY), while the FY2025 annual figure was $347.9 million, up 484.71% from the prior year.
  • Net Equity Issued and Repurchased for Q1 2026 stood at $141.9 million, up from $59.5 million in the prior quarter.
  • The five-year high for Net Equity Issued and Repurchased was $323.7 million in Q1 2023, with the low at $59.5 million in Q4 2024.
  • The 4-year median for Net Equity Issued and Repurchased is $141.9 million (2026), against an average of $167.1 million.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Equity Issued and Repurchased (Qtr)
1 Vertex Pharmaceuticals 128.13 Bn 120.28 Bn 2.84 Bn -
2 Regeneron Pharmaceuticals 112.33 Bn 104.33 Bn 3.93 Bn 49.20 Mn
3 Argenx Se 53.24 Bn 48.05 Bn 1.41 Bn -
4 Revolution Medicines 43.64 Bn 43.64 Bn - 141.90 Mn
5 BeOne Medicines 39.27 Bn 34.17 Bn 1.53 Bn -
6 MindWalk Holdings 35.32 Bn 35.31 Bn 1.82 Bn -
7 Royalty Pharma 33.72 Bn 35.84 Bn - -
8 Alnylam Pharmaceuticals 30.58 Bn 27.27 Bn 992.69 Mn -
9 Insmed 27.01 Bn 25.85 Bn 358.27 Mn -
10 Roivant Sciences 26.16 Bn 26.85 Bn 1.16 Mn -

Historic Data

Download Data
DateValue
Jun 30, 2026 141.90 Mn
Jun 30, 2026 141.90 Mn
Mar 31, 2026 141.90 Mn
Mar 31, 2026 141.90 Mn
Dec 31, 2024 59.50 Mn
Dec 31, 2024 59.50 Mn
Jun 30, 2023 62.10 Mn
Jun 30, 2023 62.10 Mn
Mar 31, 2023 323.70 Mn
Mar 31, 2023 323.70 Mn
Sep 30, 2022 248.13 Mn
Sep 30, 2022 248.13 Mn
Jun 30, 2021 -564,000.00
Jun 30, 2021 -564,000.00
Mar 31, 2021 281.71 Mn
Mar 31, 2021 281.71 Mn
Dec 31, 2020 -34,000.00
Dec 31, 2020 -34,000.00
Sep 30, 2020 167.80 Mn
Sep 30, 2020 167.80 Mn